[Elsevier] Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study |
|
This post will be closed automatically in 2026-08-04 02:47
Reward10points
|
post
reply
points
60
10
Low-power and lightweight spiking transformer for EEG-based auditory attention detection
20
Boosting photocatalytic H2O2 production and non-biodegradable ofloxacin removal via a novel Ti3C2 MXene nanosheet-supported BiVO4/InVO4 Z-scheme heterojunction: Optimization and mechanism insights
30
[Single chapter]Serotonergic psychedelics for depression: A comprehensive overview
100
A new sense for electrical fields
100
Bridging omics and physiology to build multimodal clocks of human aging